[Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment].

Fiche publication

Date publication

mars 2017


Bulletin du cancer


Membres identifiés du Cancéropôle Est :
Dr CASASNOVAS Olivier, Pr FEUGIER Pierre, Pr NERICH Virginie

Tous les auteurs :
Anthony S, Hebel P, Garrel A, Oliveri V, Thieblemont C, Ribrag V, Tilly H, Haioun C, Casasnovas RO, Morschhauser F, Feugier P, Delarue R, Ysebaert L, Sebban C, Broussais F, Damaj G, Nerich V, Jais JP, Salles G, Henry-Amar M, Mounier N


Since the introduction of targeted therapies, specific lymphoma mortality has decreased. Possible long-term toxicities, however, are not known yet. This article describes the implementation of the SIMONAL study that investigates the hypothesis of an overconsumption of care after lymphoma treatment with a 10-year follow-up.

Mots clés

Adult, Aged, Aged, 80 and over, Antineoplastic Agents, therapeutic use, Data Collection, methods, Demography, statistics & numerical data, Female, Follow-Up Studies, France, epidemiology, Health Services Needs and Demand, statistics & numerical data, Humans, Internet, Lymphoma, Non-Hodgkin, epidemiology, Male, Middle Aged, Molecular Targeted Therapy, Rituximab, therapeutic use, Surveys and Questionnaires, Time Factors


Bull Cancer. 2017 Mar;104(3):221-231